P. Warde et al., T1 T2 GLOTTIC CANCER MANAGED BY EXTERNAL-BEAM RADIOTHERAPY - THE INFLUENCE OF PRETREATMENT HEMOGLOBIN ON LOCAL-CONTROL/, International journal of radiation oncology, biology, physics, 41(2), 1998, pp. 347-353
Citations number
35
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: Pretreatment hemoglobin (Hb) level has been reported to be an
important prognostic factor for local control and survival in various
malignancies. However, in many settings, the adverse effect of a low
Hb may be related to more advanced disease. The purpose of this analys
is was to assess the influence of pretreatment Hb on local control in
a large series of patients with a localized cancer (T1/T2 glottic canc
er, AJCC 1992) treated in a standard fashion. Materials and Methods: B
etween January 1981 and December 1989, 735 patients (median age 63; 65
7 males, 78 females) with T1/T2 glottic cancer were treated with radia
tion therapy (RT). The standard RT prescription was 50 Gy in 20 fracti
ons over 4 weeks (97% of patients). Factors studied for prognostic imp
ortance for local failure included pretreatment Hb, age, sex, T catego
ry, anterior commissure involvement, subglottic extension, and tumor b
ulk (presence of visible tumor vs. subclinical disease). Results: With
a median follow up of 6.8 years (range 0.2-14.3), 131 patients have l
ocally relapsed for an actuarial 5-year relapse-free rate of 81.7%. Th
e 5-year actuarial survival was 75.8%. The mean pretreatment hemoglobi
n level was 14.8 g/dl and was similar in all prognostic categories. On
multivariate analysis, using the Cox proportional hazards model, pret
reatment Hb predicted for local failure after RT. The hazard ratio (HR
) for relapse was calculated for various Hb levels. For example, the H
R for a Hb of 12 g/dl vs, a Hb of 15 g/dl was 1.8 (95% confidence inte
rval 1.2-2.5). Previously established factors, including gender, T cat
egory, subglottic extension, as well as tumor bulk, were also prognost
ically important for local control. Conclusions: This analysis, in a l
arge number of similarly treated patients, indicates that pretreatment
Hb is an independent prognostic factor for local control in patients
with T1/T2 carcinoma of the glottis treated with RT. The underlying bi
ology of this observation needs to be explored, and using this informa
tion, it may be possible to develop strategies to improve treatment ou
tcome. (C) 1998 Elsevier Science Inc.